Biocon Biologics
Namratha Srinivas is a Principal Scientist at Biocon Biologics, with previous experience in downstream protein processing at ATUM as an Expression Technologies Associate. Namratha also worked on a Master's Project at Washington University School of Medicine in St. Louis, where Namratha designed experiments related to Alzheimer's. Additionally, Namratha has interned at inStem and worked as a Consultant at BALSA Foundation. Namratha holds a Master of Science in Bioengineering and Biomedical Engineering from Washington University and a Bachelor of Engineering in Biotechnology from B. M. S. College of Engineering.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics